MSB 2.67% 96.0¢ mesoblast limited

“There are also mesenchymal stem cells-based approaches in the...

  1. 15,616 Posts.
    lightbulb Created with Sketch. 5701
    “There are also mesenchymal stem cells-based approaches in the clinic today and some rather large Phase 3 trials are being finalized this year. It will be interesting to see the outcome of these!”

    Great find @aquazul .... like I have said previously, @The Yankee picked the synergies with AstraZeneca earlier in the year with this post (link below)

    .... and of course the CEO of AstraZeneca is in Australia at the moment so the timing is 'coincidental' with the phase 3 CHF readout due

    https://hotcopper.com.au/threads/an...624717/page-182?post_id=47370207#.X9Ve89gzbIU
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
96.0¢
Change
0.025(2.67%)
Mkt cap ! $1.096B
Open High Low Value Volume
95.0¢ 96.5¢ 94.0¢ $1.231M 1.291M

Buyers (Bids)

No. Vol. Price($)
4 94461 95.0¢
 

Sellers (Offers)

Price($) Vol. No.
96.0¢ 61151 6
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.